Patient Square Capital LP Roivant Sciences Ltd. Transaction History
Patient Square Capital LP
- $215 Billion
- Q2 2024
A detailed history of Patient Square Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Patient Square Capital LP holds 12,228,465 shares of ROIV stock, worth $143 Million. This represents 59.99% of its overall portfolio holdings.
Number of Shares
12,228,465
Previous 12,228,465
-0.0%
Holding current value
$143 Million
Previous $129 Billion
0.28%
% of portfolio
59.99%
Previous 54.89%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
314Shares Held
496MCall Options Held
991KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$834 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$808 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$779 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$413 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$343 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.23B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...